4,5-MDO-DiPT

Last updated
4,5-MDO-DiPT
4,5-MDO-DiPT.svg
4,5-MDO-DiPT 3D.png
Clinical data
Other names4,5-Methylenedioxy-N,N-diisopropyltryptamine
Routes of
administration 		Oral [1]
Drug class Serotonergic psychedelic; Hallucinogen
ATC code
  • None
Pharmacokinetic data
Duration of action Unknown [1]
Identifiers
  • N-[2-(6H-[1,3]dioxolo[4,5-e]indol-8-yl)ethyl]-N-propan-2-ylpropan-2-amine
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
Formula C17H24N2O2
Molar mass 288.391 g·mol−1
3D model (JSmol)
  • CC(C)N(CCC1=CNC2=C1C3=C(C=C2)OCO3)C(C)C
  • InChI=1S/C17H24N2O2/c1-11(2)19(12(3)4)8-7-13-9-18-14-5-6-15-17(16(13)14)21-10-20-15/h5-6,9,11-12,18H,7-8,10H2,1-4H3
  • Key:PTYYWSKZYOSFEK-UHFFFAOYSA-N

4,5-MDO-DiPT, also known as 4,5-methylenedioxy-N,N-diisopropyltryptamine, is a lesser-known psychedelic drug of the tryptamine family. [1] It is the 4,5-methylenedioxy derivative of diisopropyltryptamine (DiPT) and is an analogue of 4-HO-DiPT and 5-MeO-DiPT. [1]

Contents

Use and effects

In his book TiHKAL (Tryptamines I Have Known and Loved), Alexander Shulgin lists the dose of 4,5-MDO-DiPT as greater than 25 mg orally, whereas the duration is listed as unknown. [1] At a dose of 25 mg, nothing happened for 3 hours, then the drug suddenly onset and produced LSD-like psychedelic effects, with a plateau that lasted for a fair amount of time. [1] Higher doses were not explored. [1]

Interactions

Pharmacology

Very little data exists about the pharmacological properties, metabolism, and toxicity of 4,5-MDO-DiPT. [1]

Chemistry

Synthesis

The chemical synthesis of 4,5-MDO-DiPT has been described. [1]

Analogues

Analogues of 4,5-MDO-DiPT include diisopropyltryptamine (DiPT), 4-HO-DiPT, 5-MeO-DiPT, 4,5-MDO-DMT, 5,6-MDO-DiPT, and 4,5-DHP-DMT, among others. [1]

History

4,5-MDO-DiPT was first described in the scientific literature by Toni B. Kline and colleagues in 1982. [2] Subsequently, it was further described by Alexander Shulgin in his 1997 book TiHKAL (Tryptamines I Have Known and Loved). [1]

See also

References

  1. 1 2 3 4 5 6 7 8 9 10 11 Shulgin, Alexander; Shulgin, Ann (September 1997). TiHKAL: The Continuation. Berkeley, California: Transform Press. ISBN   0-9630096-9-9. OCLC   38503252.
  2. ↑ Kline TB, Benington F, Morin RD, Beaton JM (August 1982). "Structure-activity relationships in potentially hallucinogenic N,N-dialkyltryptamines substituted in the benzene moiety". J Med Chem. 25 (8): 908–913. doi:10.1021/jm00350a005. PMID   7120280.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.